Gorick B D, Thompson K M, Melamed M D, Hughes-Jones N C
MRC Mechanisms in Tumour Immunity Unit, MRC Centre, Cambridge, UK.
Vox Sang. 1988;55(3):165-70. doi: 10.1111/j.1423-0410.1988.tb05086.x.
Seven purified monoclonal antibodies specific for the D antigen of the human Rh blood group system were examined for the characteristics of their reactions with red cells (phenotype CcDEe). The average number of sites available for binding to the antibodies ranged from 8,900 to 26,000/cell. In mutual inhibition studies, all the antibodies inhibited each other but the extent of inhibition varied in that antibodies recognizing a lower number of sites only partially inhibited those recognizing a higher number of sites. It was concluded from the evidence that these six monoclonals recognize at least three different epitopes on the D peptide. In order to explain the variation in the number of epitopes on each polypeptide, it is suggested that there is heterogeneity in the placement of the molecule in the red cell membrane resulting in variation in access to the epitopes.
对七种针对人类Rh血型系统D抗原的纯化单克隆抗体与红细胞(表型CcDEe)的反应特性进行了检测。每个细胞上可用于与抗体结合的位点平均数在8900至26000个之间。在相互抑制研究中,所有抗体都能相互抑制,但抑制程度有所不同,即识别较少位点的抗体只能部分抑制识别较多位点的抗体。根据这些证据得出结论,这六种单克隆抗体识别D肽上至少三种不同的表位。为了解释每个多肽上表位数量的差异,有人提出,该分子在红细胞膜中的定位存在异质性,导致表位的可及性有所不同。